throbber
Trademark Trial and Appeal Board Electronic Filing System. http://estta.uspto.gov
`ESTTA197551
`ESTTA Tracking number:
`03/11/2008
`
`Filing date:
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`92048893
`Plaintiff
`TherOx, Inc.
`Tawnya R. Wojciechowski, Esq.
`TRW Law Group
`19900 Mac Arthur Blvd. Suite 1150
`Irvine, CA 92612
`UNITED STATES
`lindy@trwlawgroup.com, tawnya@trwlawgroup.com
`Other Motions/Papers
`Lindy M. Herman
`lindy@trwlawgroup.com, tawnya@trwlawgroup.com
`/lmh/
`03/11/2008
`Amended TTAB Petition to Cancel - TherRx.pdf ( 7 pages )(66402 bytes )
`
`Proceeding
`Party
`
`Correspondence
`Address
`
`Submission
`Filer's Name
`Filer's e-mail
`Signature
`Date
`Attachments
`
`

`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`Cancellation No. 92048893
`
`In the matter of
`
`U.S. Trademark Registration No. 3231059
`For the Mark: THE THER—RX CONTINUUM
`
`OF WOMEN'S CARE
`Registered on May 10’ 2005
`
`TherOx, Inc.
`
`a Delaware corporation,
`
`V.
`
`Petitioner,
`
`DrugTech Corporation,
`a Delaware corporation,
`
`Registrant.
`
`AMENDED PETITION FOR CANCELLATION
`
`Trademark Trial and Appeal Board
`U.S. Patent and Trademark Office
`
`P.O. Box 1451
`
`Alexandria, VA 22313-1451
`
`///
`
`

`
`TherOx, Inc., is a Delaware corporation having a principal place of
`
`business at 17500 Cartwright Road, Suite 100, Irvine, California 92614 (“Petitioner”),
`
`believes it is damaged by U.S. Registration. No 2,948,813 for the trademark THE THER-
`
`RX CONTINUUM OF WOMEN’S CARE & Design ( hereinafter “Registrant’s Mark” or
`
`the “THER—RX Mark”), and hereby petitions to cancel same.
`
`As grounds for cancellation, Petitioner alleges the following:
`
`1.
`
`Petitioner owns the following trademark registrations:
`
`a.
`
`THEROX, U.S. Registration No. 2285402, registered on
`
`October 12, 1999 for “medical apparatus and instruments, namely, catheters,
`
`[guidewires,] pump systems, and tubing for the preparation and delivery of physiologic
`
`solutions used to treat conditions such as tissue ischemia and post—ischemic tissues” in
`
`International Class 10;
`
`b.
`
`THEROX (stylized), U.S. Registration No. 2307292,
`
`registered on October 19, 1999 for “medical apparatus and instruments, namely,
`
`catheters, guidewires, pump systems, and tubing for the preparation and delivery of
`
`physiologic solutions used to treat conditions such as tissue ischemia and post—ischemic
`
`tissues” in International Class 10;
`
`c.
`
`THEROX & Design, U.S. Registration No. 2235609,
`
`registered on July 20, 1999 for “medical apparatus and instruments, namely, catheters,
`
`[guidewires,] pump systems, and tubing for the preparation and delivery of physiologic
`
`solutions used to treat conditions such as tissue ischemia and post—ischemic tissues” in
`
`International Class 10.
`
`‘2'
`
`PETITION FOR CANCELLATION
`
`

`
`2.
`
`Petitioner is owner of the following trademark application:
`
`a.
`
`THEROX & Design, U.S. Application Ser. No. 77/177,092,
`
`filed May 9, 2007 and published October 30, 2007 for “medical apparatus and
`
`instruments, namely, catheters, pump systems and their disposable parts sold therewith,
`
`and tubing for the preparation and delivery of physiologic solutions used to treat
`
`conditions such as tissue ischemia and post—ischemic tissues” in International Class 10.
`
`3.
`
`Petitioner is the owner of the following International Registration:
`
`a.
`
`THEROX & Design, International Registration No, 944538,
`
`Registered on November 11, 2007 for “Medical apparatus and instruments, namely,
`
`catheters, pump systems and their disposable parts sold therewith, and tubing for the
`
`preparation and delivery of physiologic solutions used to treat conditions such as tissue
`
`ischemia and post—ischemic tissues” in International Class 10.
`
`4.
`
`Registrant's original application for registration number 2,948,813
`
`was filed on May 6, 2002 for the mark THE THER—RX CONTINUUM OF WOMEN’S
`
`CARE & Design. The Registrant's Mark was registered on the Principal Register on May
`
`10, 2005 in International Class 5 for “nutritional supplements; prenatal nutritional
`
`supplements, vitamins and pharmaceutical and therapeutic substances, oral
`
`contraceptives, anti—infective, electrolytes, fertility enhancement preparations and agents,
`
`anti—inflammatories, nausea treatment preparations and agents, hormones, analgesics,
`
`migraine treatment preparations, muscle relaxants, nausea treatment preparations and
`
`agents for the treatment of a wide variety of illnesses, diseases and medical conditions,
`
`namely, neonatal conditions, osteoporotic conditions, aging, migraines, hypokalemia,
`
`' 3 '
`
`PETITION FOR CANCELLATION
`
`

`
`menopause, fungal and microbial infections, virological infections, infertility, conception,
`
`osteoporosis, muscle pain, hormone replacement therapy, and morning sickness,”
`
`claiming a date of first use of March 22, 2002.
`
`5.
`
`Registrant's mark is Q incontestable in that it has @ been
`
`registered for more than five years in the USPTO.
`
`6.
`
`Petitioner, together with its predecessors—in—interest, successors—in—
`
`interest, subsidiary entities, affiliated entities and authorized licensees (collectively
`
`“Petitioner”) has been continuously using the THEROX mark in association with medical
`
`devices, in interstate commerce since at least as early as 1996.
`
`7.
`
`Ever since its adoption and use of the THEROX mark, Petitioner has
`
`extensively sold, advertised and promoted its THEROX products. As a consequence, the
`
`consuming public, especially medical and healthcare community, have come to
`
`recognize, and do recognize, the THEROX mark as being used exclusively by Petitioner,
`
`and to associate and identify such goods offered under the THEROX mark as emanating
`
`from a single source, namely Petitioner.
`
`8.
`
`Petitioner has derived substantial goodwill and value from its
`
`identification with the THEROX mark in its business and within the medical and
`
`healthcare community.
`
`9.
`
`Petitioner’s THEROX mark is famous and distinctive within the
`
`meaning of the Federal Dilution Act. In fact, Petitioner’s medical devices have become
`
`known as cutting—edge products embodying highly advanced technology. Registrant filed
`
`its Application after Petitioner’s THEROX mark became famous.
`
`‘4‘
`
`PETITION FOR CANCELLATION
`
`

`
`10.
`
`Registrant’s THER—RX Mark is virtually identical to Petitioner’s
`
`THEROX mark, for substantially identical goods, and highly related goods. As such,
`
`Registrant’s mark is confusingly similar in sight, and commercial impression as to the
`
`previously used, well—known, and famous THEROX mark used by Petitioner.
`
`11.
`
`For many years and since long before Registrant’s filing date and/or
`
`first use, actual or constructive, Petitioner has been engaged in the business of producing
`
`medical devices for the healthcare industry under its THEROX mark. Consequently, the
`
`goods set forth in the subject registration and the goods of Petitioner are highly related, if
`
`not virtually identical.
`
`12.
`
`Upon information and belief, Registrant’s adoption and use of, and
`
`the THER—RX Mark was intentionally done with a view and purpose of trading on and
`
`pirating away the substantial reputation and goodwill associated with Petitioner’s
`
`THEROX mark. Upon information and belief, Registrant adopted the confusingly similar
`
`THEROX mark in order to give its customers and clientele appeal and salability that such
`
`mark would not otherwise possess.
`
`13.
`
`Registrant’s THER—RX Mark, when used in connection with
`
`Registrant’s goods as identified in the subject registration, so resembles Petitioner’s
`
`previously used THEROX mark so as to be likely to cause confusion, to cause mistake,
`
`and/or to deceive members of the public concerning an affiliation, connection,
`
`association or sponsorship relationship with the source of the or goods provided under
`
`Petitioner’s THEROX mark and would dilute the distinctive quality of Petitioner’s
`
`' 5 '
`
`PETITION FOR CANCELLATION
`
`

`
`THER—RX Mark, in violation of in violation of Section 43(a) of the Lanham Act, 15
`
`U.S.C. 1125(a).
`
`14. In addition, Registrant’s THER—RX Mark dilutes the distinctive
`
`quality of Petitioner’s famous THEROX Mark, in violation of Section 43 (c) of the
`
`Lanham Act 15 U.S.C. Section 1125(c)
`
`THEREFORE, Petitioner requests that registration of the above-referenced mark
`
`be cancelled and this Petition be granted.
`
`This Petition for Cancellation is being filed electronically, along with the filing fee
`
`required by 37 C.F.R. §2.6(a)(16). Any required fees not submitted with this Notice are
`
`authorized to be deducted from Deposit Account No. 503593.
`
`Dated: March 11, 2008
`
`Respectfully submitted,
`
`ByMy/T
`Tawnya R. Wojciechowski, Esquire
`Lindy M. Herman, Esquire
`TRW Law Group
`19900 MacArthur Boulevard, Suite 1150
`
`Irvine, California 92612-8433
`
`(949) 701-4747 phone
`(949) 701-4712 fax
`
`Attorneys for Petitioner
`TherOx, Inc.
`
`PETITION FOR CANCELLATION
`
`

`
`PROOF OF SERVICE BY MAIL
`
`I, the undersigned, declare that I am, and was at the time of service of the
`papers herein referred to, over the age of 18 years and not a party to the within action or
`proceeding. My business address is TRW Law Group, 19900 MacArthur Boulevard,
`Suite 1 150, Irvine, California 92612, which is located in the county in which the
`within—mentioned mailing occurred. I am readily familiar with the practice at my place
`of business for collection and processing of correspondence for mailing with the United
`States Postal Service. Such correspondence will be deposited with the United States
`Postal Service on the same day in the ordinary course of business.
`
`On March 11, 2008 I served the following document(s):
`
`AMENDED PETITION FOR CANCELLATION
`
`by placing a true copy in a separate envelope for each addressee named below, with the name
`and address of the persons served shown on the envelope as follows:
`
`DrugTech Corporation
`900 Market Street
`Wilmington, DE 19801
`
`Bassam N. Ibrahim, Esq.
`Buchanan Ingersoll & Rooney, P.C.
`PO Box 1404
`Alexandria, VA 223 13-1404
`bassam.ibrahim@bpic.com
`(703)836-6620
`and by sealing the envelope and placing it in the appropriate location at my place of
`business for collection and mailing with postage fully prepaid in accordance with
`ordinary business practices
`
`(
`
`)
`
`(X)
`
`State
`
`I declare under penalty of perjury under the laws of the
`State of California that the foregoing is true and correct.
`
`Federal
`
`I declare under penalty of perjury under the laws of the
`United States of America that the foregoing is true and
`correct and that I am employed in the office of a member
`of the bar of this Court at whose direction the service was
`made.
`
`Executed on March ll, 2008 at Irvine, California.
`
`zlwéwtw
`
`Diane Barnes

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket